Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 14Breast 7Myeloid 6Thoracic 5Gynecologic 3Genitourinary 3Dermatologic 3Classical hematology 3Plasma cell 2Head & Neck 2CNS 2Tumor-Agnostic 1Other neoplasm 1Other hematologic neoplasm 1

Conditions

Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 315Radiotherapy 139Cetuximab 133pembrolizumab 131Docetaxel 122Carboplatin 119Radiotherapy, Intensity-Modulated 97Fluorouracil 94Paclitaxel 92Nivolumab 64Gemcitabine 50toripalimab 46Radiation 44Drug Therapy 39Capecitabine 39Magnetic Resonance Spectroscopy 38Surgical Procedures, Operative 33camrelizumab 31130-nm albumin-bound paclitaxel 29apatinib 27tislelizumab 26Chemoradiotherapy 26Specimen Handling 25Bevacizumab 24durvalumab 23Albumin-Bound Paclitaxel 23nimotuzumab 22lenvatinib 21Sorafenib 21Platinum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Aspirin × Head & Neck × Clear all
NCT03290820 2017-10-26

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Sun Yat-sen University

Phase 2 Unknown
184 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡